Lawlor Sally Bridget — SEC Form 4 filings

SEC reporting owner CIK 2084407. 3 Form 4 filings on record with FilingPulse; latest filed 2026-09-01.

Transaction summary — filings shown

Covers all 3 filings on record, filed 2025-12-03 to 2026-09-01. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Quoin Pharmaceuticals, Ltd. (QNRX)Chief Financial Officer31 leg · 10,244 sh · $49,9913

Form 4 filings — Lawlor Sally Bridget

FiledFormIssuerReported transactionsSource
2026-09-014Quoin Pharmaceuticals, Ltd. (QNRX)Purchase (P): 10,244 @ $4.88 · Purchase (P): 5,122 (derivative)EDGAR
2026-02-064Quoin Pharmaceuticals, Ltd. (QNRX)Grant/award (A): 85,250 (derivative) @ $0EDGAR
2025-12-034Quoin Pharmaceuticals, Ltd. (QNRX)Grant/award (A): 10,330 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=2084407 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →